Skip to main content

Advertisement

SpringerLink
Log in

Retroperitoneal and Truncal Sarcomas: Prognosis Depends Upon Type Not Location

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Prognostication of truncal and retroperitoneal soft tissue sarcomas has traditionally been predicated on tumor location and grade.

Objective

To compare outcomes for patients with retroperitoneal or truncal sarcomas.

Methods

Retrospective analysis of a prospective cancer data registry from 1977 to 2004 was performed and outcomes were determined.

Results

The study group numbered 312 patients (median age 58 years, 54% male, 56% Caucasian, 14% black, 29% Hispanic). The most common tumor types were liposarcoma (35.9%), leiomyosarcoma (30.1%), and malignant fibrous histiocytoma (MFH) (19.5%). Tumor distributions were retroperitoneal (38.9%), pelvic (24.7%), abdominal (18.6%) and thoracic (17.9%). Median overall survival was 74 months. Operative resection was undertaken in 89.4% of cases and multiple surgeries (range 2–5) in 42.2%. Negative resection margins were obtained in 72.7% of patients. Univariate analysis comparing retroperitoneal versus truncal location demonstrated no significant differences in survival. Survival was improved in lower grade tumors (P < 0.02). Liposarcoma and fibrosarcoma were associated with improved survival (P < 0.0001). Multivariate analysis of pre-treatment variables showed increasing age, grade, histopathology (leiomyosarcoma and MFH) and metastasis to be associated with worse outcomes. Multivariate analysis of the treatment variables showed that surgery and negative resection margins were associated with improved survival (P < 0.001). No advantage for chemoradiotherapy could be demonstrated.

Conclusions

Successful operative resection can confer prolonged disease-free survival and cure for truncal and retroperitoneal sarcomas. Histological subtype, not location, is predictive of long-term survival. Future studies should focus on histological subtype rather than tumor location for truncal and retroperitoneal sarcomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG. 3.
FIG. 4.

Similar content being viewed by others

References

  1. Lawrence W Jr, Donegan WL, Natarajan N, et al. Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg 1987; 205(4):349–59

    Article  PubMed  Google Scholar 

  2. Windham TC, Pisters PW. Retroperitoneal sarcomas. Cancer Control 2005; 12(1):36–43

    PubMed  Google Scholar 

  3. Massi D, Beltrami G, Capanna R, Franchi A. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance. Eur J Surg Oncol 2004; 30(10):1131–6

    Article  PubMed  CAS  Google Scholar 

  4. Pollock R. Soft tissue sarcoma: setting the stage. Ann Surg Oncol 2001; 8(4):273–4

    Article  PubMed  CAS  Google Scholar 

  5. Wunder JS, Healey JH, Davis AM, Brennan MF. A comparison of staging systems for localized extremity soft tissue sarcoma. Cancer 2000; 88(12):2721–30

    Article  PubMed  CAS  Google Scholar 

  6. Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nat Rev Cancer 2003; 3(9):685–94

    Article  PubMed  CAS  Google Scholar 

  7. Clary BM, DeMatteo RP, Lewis JJ, et al. Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol 2001; 8(4):290–9

    Article  PubMed  CAS  Google Scholar 

  8. Borden EC, Baker LH, Bell RS, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res 2003; 9(6):1941–56

    PubMed  Google Scholar 

  9. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279(5350):577–80

    Article  PubMed  CAS  Google Scholar 

  10. Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002; 3(11):655–64

    Article  PubMed  CAS  Google Scholar 

  11. Perez EA, Livingstone AS, Franceschi D, et al. Current Incidence and Outcomes of Gastrointestinal Mesenchymal Tumors including GIST. J Am Coll Surg 2006 (in press)

  12. Torres U, Hawkins WG, Antonescu CR, DeMatteo RP. Hepatic follicular dendritic cell sarcoma without Epstein-Barr virus expression. Arch Pathol Lab Med 2005; 129(11):1480–3

    PubMed  Google Scholar 

  13. Khanna A, Walker G, Livingstone AS, et al. Does adjuvant 5-FU prolongs survival following pancreaticoduodenectomy? A meta-analysis. J Gastrointest Surg 2006 (in press)

  14. Oda Y, Tamiya S, Oshiro Y, et al. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Pathol Int 2002; 52(9):595–606

    Article  PubMed  Google Scholar 

  15. Miyajima K, Oda Y, Oshiro Y, et al. Clinicopathological prognostic factors in soft tissue leiomyosarcoma: a multivariate analysis. Histopathology 2002; 40(4):353–9

    Article  PubMed  CAS  Google Scholar 

  16. Antonescu CR, Viale A, Sarran L, et al. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site. Clin Cancer Res 2004; 10(10):3282–90

    Article  PubMed  CAS  Google Scholar 

  17. Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228(3):355–65

    Article  PubMed  CAS  Google Scholar 

  18. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001; 92(2):359–68

    Article  PubMed  CAS  Google Scholar 

  19. Cormier JN, Huang X, Xing Y, et al. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes. J Clin Oncol 2004; 22(22):4567–74

    Article  PubMed  Google Scholar 

  20. Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995; 221(2):185–95

    Article  PubMed  CAS  Google Scholar 

  21. Koch BB, Karnell LH, Hoffman HT, et al. National cancer database report on chondrosarcoma of the head and neck. Head Neck 2000; 22(4):408–25

    Article  PubMed  CAS  Google Scholar 

  22. Sindwani R, Matthews TW, Thomas J, Venkatesan VM. Epithelioid leiomyosarcoma of the larynx. Head Neck 1998; 20(6):563–7

    Article  PubMed  CAS  Google Scholar 

  23. Linehan DC, Lewis JJ, Leung D, Brennan MF. Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol 2000; 18(8):1637–43

    PubMed  CAS  Google Scholar 

  24. Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer 2004; 100(11):2448–55

    Article  PubMed  Google Scholar 

  25. Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003; 238(3):358–70; discussion 370–1

    PubMed  Google Scholar 

  26. Gilbeau L, Kantor G, Stoeckle E, et al. Surgical resection and radiotherapy for primary retroperitoneal soft tissue sarcoma. Radiother Oncol 2002; 65(3):137–43

    Article  PubMed  Google Scholar 

  27. Mendenhall WM, Zlotecki RA, Hochwald SN, et al. Retroperitoneal soft tissue sarcoma. Cancer 2005; 104(4):669–75

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Jackson Memorial Hospital, Miami, FL, USA

    Eduardo A. Perez MD, Juan C. Gutierrez MD, Frederick L. Moffat Jr MD, Dido Franceschi MD, Alan S. Livingstone MD, Seth A. Spector MD, Joe U. Levi MD, Danny Sleeman MD & Leonidas G. Koniaris MD

  2. Alan Livingstone Chair in Surgical Oncology, University of Miami School of Medicine, 3550 Sylvester Comprehensive Cancer Center, 1475 NW 12th Ave, Miami, FL, 33136, USA

    Leonidas G. Koniaris MD

Authors
  1. Eduardo A. Perez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan C. Gutierrez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frederick L. Moffat Jr MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dido Franceschi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alan S. Livingstone MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seth A. Spector MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joe U. Levi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Danny Sleeman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Leonidas G. Koniaris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leonidas G. Koniaris MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perez, E.A., Gutierrez, J.C., Moffat, F.L. et al. Retroperitoneal and Truncal Sarcomas: Prognosis Depends Upon Type Not Location. Ann Surg Oncol 14, 1114–1122 (2007). https://doi.org/10.1245/s10434-006-9255-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9255-x

Key Words

Search

Navigation